Table 2.
Outcome | Pretest | Posttest | Mean difference | t | 95% CI | P |
---|---|---|---|---|---|---|
Stroke-knowledge questionnaire | ||||||
Total score | ||||||
Intervention a | 26.23 ± 6.65 | 29.07 ± 5.27 | −2.83 ± 4.51 | −3.440 | −4.52 to −1.15 | 0.002* |
Control b | 25.21 ± 5.54 | 28.00 ± 5.46 | − 2.79 ± 4.36 | −3.676 | − 4.33 to − 1.24 | 0.001** |
Health-related quality of life (European Quality of Life–Five Dimensions) | ||||||
Index | ||||||
Intervention a | 0.55 ± 0.29 | 0.62 ± 0.29 | −0.07 ± 0.22 | −1.640 | −0.15 to 0.02 | 0.11 |
Control b | 0.54 ± 0.40 | 0.46 ± 0.40 | 0.08 ± 0.34 | 1.426 | −0.04 to 0.20 | 0.16 |
Visual analog scale | ||||||
Intervention a | 59.67 ± 20.17 | 62.30 ± 18.77 | −2.63 ± 18.81 | −0.767 | −9.66 to 4.39 | 0.45 |
Control b | 61.63 ± 22.33 | 65.00 ± 18.37 | −3.64 ± 19.89 | −1.050 | −10.69 to 3.41 | 0.30 |
*P < .01; **P < .001. a n = 30; b n = 33; CI, confidence interval; data were mean ± SD